After chemotherapy and radiotherapy for nonHodgkin's lymphoma during a one-year period, a 66-year-old mandeveloped synchronous triple lung cancers in both lungs. Of the three resected tumors, one was advanced large cell carcinoma with neuroendocrine morphology, and the other two were early squamouscell carcinoma without lymph node metastasis. Although he received repeated chemotherapy for lung cancer, the patient died of hepatic failure due to multiple liver metastases. Autopsy revealed disseminated metastasis of the large cell carcinoma with neuroendocrine morphology throughout the entire body, but no recurrence of malignant lymphoma or squamouscell carcinoma was found. To our knowledge, this is the first report of triple lung cancers occurring after treatment for malignant lymphoma.
Introduction
As a result of successful treatment of lymphomas with chemotherapy, radiation therapy, or both, patients with lymphoma are living longer. However, this improved survival has increased the risk of treatment-related complications, including second malignancies.
Here, we report a rare case in which synchronous triple lung cancers developed in one patient after treatment for non-Hodgkin' s lymphoma (NHL).
Case Report
On February 16, 2000, a 66-year-old man was admitted to our hospital with abnormal shadows on his chest computed tomography (CT). There were two abnormal shadows in lung fields on his chest CT, with no hilar or mediastinal lymph node swelling: Onewas an approximate 15 mmround nodule on S6 in the right lower lung lobe, the other, a 6 mm round nodule on Sl+2 in the left upper lung lobe (Fig. 1A , B). These abnormalities had not been detected on his chest CT taken in July 1999 (Fig. 1C, D cell carcinomas without lymph node metastasis. Hence, we diagnosed his illness as synchronous triple lung cancers according to the definition proposed by Warren and Gates (1). In October 2001, abdominal CT revealed multiple liver tumors and the patient was admitted to our hospital again. Liver biopsy under ultrasonography was performed, and the diagnosis was metastases of large cell carcinoma with neuroendocrine morphology. The serum level of CYFRA was elevated at 9.5 ng/ml, and CEA was high at 94.3 ng/ml (normal <5.0). Although he received repeated chemotherapy treatments of paclitaxel, gemcitabine and vinorelbine, the patient died on January 29, 2002 (4) . The largest number of second tumors, 274 of the 1,231 patients (22.3%), occurred in the lung at a median 40 months after diagnosis of NHL (4). Travis et al recently also reported that a significant risk of lung cancer after Hodgkin's disease was apparent within 1-4 years after treatment with alkylating agents, whereas excess risk after radiotherapy became a factor 5 years after treatment and persisted for more than 20 years (5). The triple lung cancers in the present patient developed over the course of a year, during treatment for malignant lymphoma after initial diagnosis. The period of one year was quite short, but it was compatible with the second report, above (5) . To the best of our knowledge, however, double second lung cancers after malignant lymphoma had not been reported before, nor have synchronous triple lung cancers. We do not really understand how these three lung cancers developed in such a short term, but we have made a speculation. Recent understanding of molecular carcinogenesis has provided a concept of multistage carcinogenesis that is separated into initiation, promotion, conversion, and progression.
Combined chemotherapy for malignant lymphoma might accelerate these steps, possibly resulting in the three lung cancers that appeared synchronously.
There have been reports of a positive correlation between a history of smoking and the development of lung cancer after malignant lymphoma (6, 7) , and, since our patient was a heavy smoker, his habit probably played a role in the development of the lung cancers. Although he had been treated with radiation, his lung cancers were outside the radiation area, so there was little likelihood of a causal relationship between radiation and the lung cancers.
In this case, we diagnosed triple primary lung cancers and proceeded to operate for a tumor. Had we not done so, we would have diagnosed recurrence of the former malignant neoplasm. Thus, obtaining tumor tissue from patients with a history of treatment for malignant neoplasm can lead clinicians to more definitive diagnoses. According to the Annual of the Pathological Autopsy Cases in 1999 in Japan, the frequency of triple lung cancers was 6 cases of 26,619 autopsy cases (0.02%), and the occurrence of quadruple cancers was 30 cases (0.1%) (8) . Both were very rare incidents. In conclusion, the present case suggests that the current treatment of lymphomas has improved survival but that it can also lead to an increased risk of second malignancies. We report this case to remind physicians to take this risk into consideration.
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